CoChat

β2-1 Fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: results from a randomised controlled trial

Open access
Lomax, Amy R., Cheung, Lydia V. Y., Tuohy, Kieran M., Noakes, Paul S., Miles, Elizabeth A., Calder, Philip C. · 2012 · British Journal of Nutrition
Cited by 47

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

β2-1 fructans are considered to be prebiotics. Current literature indicates that β2-1 fructans may modulate some aspects of immune function, improve the host's ability to respond to certain intestinal infections, and modify some inflammatory outcomes in human subjects. However, there is a need to find out more about the modulation of immune markers by β2-1 fructans in humans. Healthy human subjects aged 45–65 years were randomly allocated to β2-1 fructans (Orafti® Synergy1; 8 g/d; n 22) or the digestible carbohydrate maltodextrin as placebo (n 21) for 4 weeks. Blood, saliva and faecal samples were collected at study entry and after 4 weeks. Immune parameters were measured using the blood and saliva samples and bifidobacteria were measured in the faecal samples. Faecal bifidobacteria numbers increased in the Orafti® Synergy1 group (P < 0·001) and were different at 4 weeks from numbers in the placebo group (P = 0·001). There was no significant effect of Orafti® Synergy1 on any of the immune parameters measured (blood immune cell subsets, total serum Ig, salivary IgA, neutrophil and monocyte phagocytosis of Escherichia coli and respiratory burst in response to E. coli or phorbol ester, natural killer cell activity, T cell activation and proliferation, production of six cytokines by T cells). It is concluded that, compared with maltodextrin, Orafti® Synergy1 has a bifidogenic effect in healthy middle-aged human subjects but does not alter immune responses examined in the absence of an in vivo immune challenge.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0007114511007276

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 25

  1. 10.1017/S0007114507709091 · DOI · Paper page
  2. 10.1111/j.1532-5415.2004.52003.x · DOI · Paper page
  3. 10.1093/jn/138.6.1141 · DOI · Paper page
  4. 10.1007/s00268-005-0653-1 · DOI · Paper page
  5. 10.1177/0148607104028005348 · DOI · Paper page
  6. 10.1093/ajcn/85.2.488 · DOI · Paper page
  7. 10.1136/adc.2006.098251 · DOI · Paper page
  8. 10.1093/jn/130.5.1197 · DOI · Paper page
  9. 10.1017/S0007114507328626 · DOI · Paper page
  10. 10.1017/S000711451000036X · DOI · Paper page
  11. 10.1017/S0007114510003363 · DOI · Paper page
  12. 10.1111/j.1462-2920.2009.02066.x · DOI · Paper page
  13. 10.1111/j.1399-3038.2005.00370.x · DOI · Paper page
  14. 10.1186/1475-2859-10-S1-S10 · DOI · Paper page
  15. 10.1097/MCG.0b013e31821f44c4 · DOI · Paper page
  16. 10.1079/BJN2001394 · DOI · Paper page
  17. 10.1079/BJN20051469 · DOI · Paper page
  18. 10.1111/j.1532-5415.2006.00982.x · DOI · Paper page
  19. Firmansyah, 2001, Improved humoral immune response to measles vaccine in infants receiving infant cereal with fructooligosaccharides, JPGN, 31, A521
  20. 10.1038/ejcn.2009.64 · DOI · Paper page
  21. 10.1152/ajpgi.00052.2006 · DOI · Paper page
  22. Van Loo, 1999, Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095), Br J Nutr, 81, 121, 10.1017/S0007114599000252 · DOI · Paper page
  23. 10.1016/S0271-5317(01)00354-2 · DOI · Paper page
  24. Schiffrin, 2007, Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics, J Nutr Health Aging, 11, 475
  25. 10.1017/S0007114507730751 · DOI · Paper page

Cited by

See all 47

Metadata

Authors
Lomax, A. R., Cheung, L. V. Y., Tuohy, K. M., Noakes, P. S., Miles, E. A., & Calder, P. C.
Venue
British Journal of Nutrition
Published
2012-01-16
Volume
108
Issue
10
Pages
1818-1828
ISSN
  • 0007-1145 (ISSN-L)
  • 1475-2662
OpenAlex
W2092006436
Cited by
47
References
10
FWCI
2.63
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: β2-1 Fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: results from a randomised controlled trial. https://app.cochat.ai/papers/10.1017/s0007114511007276
The paper
Lomax, A. R., Cheung, L. V. Y., Tuohy, K. M., Noakes, P. S., Miles, E. A., & Calder, P. C. (2012). β2-1 Fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: results from a randomised controlled trial. British Journal of Nutrition. https://doi.org/10.1017/s0007114511007276

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.